This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder
and you are
between 8 and 21
years old
This is an early phase trial to investigate
how or whether the drug affects your body.
Show me locations

The purpose

The overall goal of this research is to use neurophysiological measures to profile strengths and deficits for Attention Deficit Hyperactivity Disorder co-morbidity in Autism Spectrum Disorder to clarify diagnosis and to predict treatment response.

Provided treatments

  • Drug: Methylphenidate
  • Drug: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02874690. The sponsor of the trial is Children's Hospital Medical Center, Cincinnati and it is looking for 40 volunteers for the current phase.
Official trial title:
Title: Eye Tracking as a Predictor of Methylphenidate Response in Autism With Co-morbid Attention Deficit Hyperactivity Disorder